Published 12 days ago • loading... • Updated 12 days ago
BOND Trial Aims to Improve Support for Families Facing Congenital Heart Disease
The BOND trial stands for Building Optimal Strategies to Enhance Parent and Infant Wellbeing in Congenital Heart Disease and aims to support families facing this condition.
The BOND trial seeks to improve support for parents after their baby is diagnosed with a serious congenital heart condition by developing care models that make parents feel supported and capable early on.
HeartGPS, part of BOND, provides telemedicine psychological support to mothers starting before birth to reduce anxiety, stress, and depressive symptoms.
Research suggests that breastfeeding benefits infants with congenital heart disease by reducing medical complications and supports mother-child bonding and maternal mental health.